Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
Ashley Sunderland(University of Leeds), Mihaela Lorger(University of Leeds), Christopher M. Fife(St James's University Hospital), Valerie Speirs(University of Aberdeen), Jennifer M. Williams(South African Medical Research Council), Tereza Andreou(University of Leeds), Nora Rippaus(University of Leeds), Alastair Droop(Wellcome Sanger Institute), Fiona James(Leeds Teaching Hospitals NHS Trust), Ian Carr(Areté Associates (United States)), Yolanda Dyah Kartika(University of Leeds)
Cited by 20
Related Papers
Pan-cancer image-based detection of clinically actionable genetic alterations
|Nature Cancer|2020|674
Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
|Journal of Clinical Oncology|2008|464
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
|The American Journal of Human Genetics|2007|449
Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation
|Nucleic Acids Research|2012|442
Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
|American Journal Of Pathology|2010|353